-
1
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695
-
(2005)
N Engl J Med
, vol.352
, pp. 1685-1695
-
-
Hansson, G.K.1
-
2
-
-
0036852699
-
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
-
Libby P, Aikawa M: Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 2002, 8:1257-1262
-
(2002)
Nat Med
, vol.8
, pp. 1257-1262
-
-
Libby, P.1
Aikawa, M.2
-
3
-
-
24744440988
-
Immunology of ischemic vascular disease: Plaque to attack
-
Hallenbeck JM, Hansson GK, Becker KJ: Immunology of ischemic vascular disease: plaque to attack. Trends Immunol 2005, 26:550-556
-
(2005)
Trends Immunol
, vol.26
, pp. 550-556
-
-
Hallenbeck, J.M.1
Hansson, G.K.2
Becker, K.J.3
-
4
-
-
0022523129
-
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
-
Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138
-
(1986)
Arteriosclerosis
, vol.6
, pp. 131-138
-
-
Jonasson, L.1
Holm, J.2
Skalli, O.3
Bondjers, G.4
Hansson, G.K.5
-
5
-
-
0030017111
-
Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice
-
Emeson EE, Shen ML, Bell CG, Qureshi A: Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol 1996, 149:675-685
-
(1996)
Am J Pathol
, vol.149
, pp. 675-685
-
-
Emeson, E.E.1
Shen, M.L.2
Bell, C.G.3
Qureshi, A.4
-
6
-
-
0034642328
-
Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice
-
Zhou X, Nicoletti A, Elhage R, Hansson GK: Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922
-
(2000)
Circulation
, vol.102
, pp. 2919-2922
-
-
Zhou, X.1
Nicoletti, A.2
Elhage, R.3
Hansson, G.K.4
-
7
-
-
0033048632
-
Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophagestimulating cytokines
-
Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK: Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophagestimulating cytokines. Atherosclerosis 1999, 145:33-43
-
(1999)
Atherosclerosis
, vol.145
, pp. 33-43
-
-
Frostegard, J.1
Ulfgren, A.K.2
Nyberg, P.3
Hedin, U.4
Swedenborg, J.5
Andersson, U.6
Hansson, G.K.7
-
8
-
-
3042588831
-
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
-
Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801
-
(2004)
Physiol Rev
, vol.84
, pp. 767-801
-
-
Owens, G.K.1
Kumar, M.S.2
Wamhoff, B.R.3
-
9
-
-
0030067819
-
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes
-
Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, Birkenbach M: A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 1996, 70:1143-1153
-
(1996)
J Virol
, vol.70
, pp. 1143-1153
-
-
Devergne, O.1
Hummel, M.2
Koeppen, H.3
Le Beau, M.M.4
Nathanson, E.C.5
Kieff, E.6
Birkenbach, M.7
-
10
-
-
0030700003
-
Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin
-
Devergne O, Birkenbach M, Kieff E: Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997, 94:12041-12046
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 12041-12046
-
-
Devergne, O.1
Birkenbach, M.2
Kieff, E.3
-
11
-
-
18444385868
-
IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells
-
Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal Malefyt R, Rennick D, Kastelein RA: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790
-
(2002)
Immunity
, vol.16
, pp. 779-790
-
-
Pflanz, S.1
Timans, J.C.2
Cheung, J.3
Rosales, R.4
Kanzler, H.5
Gilbert, J.6
Hibbert, L.7
Churakova, T.8
Travis, M.9
Vaisberg, E.10
Blumenschein, W.M.11
Mattson, J.D.12
Wagner, J.L.13
To, W.14
Zurawski, S.15
McClanahan, T.K.16
Gorman, D.M.17
Bazan, J.F.18
de Waal Malefyt, R.19
Rennick, D.20
Kastelein, R.A.21
more..
-
12
-
-
36549030784
-
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
-
Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA: The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569
-
(2007)
Nature
, vol.450
, pp. 566-569
-
-
Collison, L.W.1
Workman, C.J.2
Kuo, T.T.3
Boyd, K.4
Wang, Y.5
Vignali, K.M.6
Cross, R.7
Sehy, D.8
Blumberg, R.S.9
Vignali, D.A.10
-
13
-
-
36248970671
-
IL-35 is a novel cytokine with therapeutic effects against collageninduced arthritis through the expansion of regulatory T cells and suppression of Th17 cells
-
Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY: IL-35 is a novel cytokine with therapeutic effects against collageninduced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029
-
(2007)
Eur J Immunol
, vol.37
, pp. 3021-3029
-
-
Niedbala, W.1
Wei, X.Q.2
Cai, B.3
Hueber, A.J.4
Leung, B.P.5
McInnes, I.B.6
Liew, F.Y.7
-
14
-
-
0035156672
-
Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: Involvement of syncytiotrophoblasts and extravillous trophoblasts
-
Devergne O, Coulomb-L"Hermine A, Capel F, Moussa M, Capron F: Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 2001, 159:1763-1776
-
(2001)
Am J Pathol
, vol.159
, pp. 1763-1776
-
-
Devergne, O.1
Coulomb-L2
Hermine, A.3
Capel, F.4
Moussa, M.5
Capron, F.6
-
15
-
-
24944473034
-
NF-kappaB controls the global pro-inflammatory response in endothelial cells: Evidence for the regulation of a pro-atherogenic program
-
Kempe S, Kestler H, Lasar A, Wirth T: NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res 2005, 33:5308-5319
-
(2005)
Nucleic Acids Res
, vol.33
, pp. 5308-5319
-
-
Kempe, S.1
Kestler, H.2
Lasar, A.3
Wirth, T.4
-
16
-
-
1142311547
-
Expression of IL-27 in human Th1-associated granulomatous diseases
-
Larousserie F, Pflanz S, Coulomb-L"Hermine A, Brousse N, Kastelein R, Devergne O: Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 2004, 202:164-171
-
(2004)
J Pathol
, vol.202
, pp. 164-171
-
-
Larousserie, F.1
Pflanz, S.2
Coulomb-L3
Hermine, A.4
Brousse, N.5
Kastelein, R.6
Devergne, O.7
-
17
-
-
0036839934
-
Frequent expression of the Epstein-Barr virus (EBV)-induced gene. EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells
-
Niedobitek G, Pazolt D, Teichmann M, Devergne O: Frequent expression of the Epstein-Barr virus (EBV)-induced gene. EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol 2002, 198:310-316
-
(2002)
J Pathol
, vol.198
, pp. 310-316
-
-
Niedobitek, G.1
Pazolt, D.2
Teichmann, M.3
Devergne, O.4
-
18
-
-
33745712773
-
-
Larousserie F, Bardel E, Coulomb LHermine A, Canioni D, Brousse N, Kastelein RA, Devergne O: Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J Pathol 2006, 209:360-368
-
Larousserie F, Bardel E, Coulomb L"Hermine A, Canioni D, Brousse N, Kastelein RA, Devergne O: Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J Pathol 2006, 209:360-368
-
-
-
-
19
-
-
0037168543
-
Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice
-
Nieuwenhuis EE, Neurath MF, Corazza N, Iijima H, Trgovcich J, Wirtz S, Glickman J, Bailey D, Yoshida M, Galle PR, Kronenberg M, Birkenbach M, Blumberg RS: Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA 2002, 99:16951-16956
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 16951-16956
-
-
Nieuwenhuis, E.E.1
Neurath, M.F.2
Corazza, N.3
Iijima, H.4
Trgovcich, J.5
Wirtz, S.6
Glickman, J.7
Bailey, D.8
Yoshida, M.9
Galle, P.R.10
Kronenberg, M.11
Birkenbach, M.12
Blumberg, R.S.13
-
20
-
-
17444387109
-
Impaired Th1 responses in mice deficient in Epstein-Barr virusinduced gene 3 and challenged with physiological doses of Leishmania major
-
Zahn S, Wirtz S, Birkenbach M, Blumberg RS, Neurath MF, von Stebut E: Impaired Th1 responses in mice deficient in Epstein-Barr virusinduced gene 3 and challenged with physiological doses of Leishmania major. Eur J Immunol 2005, 35:1106-1112
-
(2005)
Eur J Immunol
, vol.35
, pp. 1106-1112
-
-
Zahn, S.1
Wirtz, S.2
Birkenbach, M.3
Blumberg, R.S.4
Neurath, M.F.5
von Stebut, E.6
-
21
-
-
40449122918
-
Cutting edge: A key pathogenic role of IL-27 in T cellmediated hepatitis
-
Siebler J, Wirtz S, Frenzel C, Schuchmann M, Lohse AW, Galle PR, Neurath MF: Cutting edge: a key pathogenic role of IL-27 in T cellmediated hepatitis. J Immunol 2008, 180:30-33
-
(2008)
J Immunol
, vol.180
, pp. 30-33
-
-
Siebler, J.1
Wirtz, S.2
Frenzel, C.3
Schuchmann, M.4
Lohse, A.W.5
Galle, P.R.6
Neurath, M.F.7
-
22
-
-
0344304399
-
IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms
-
Lucas S, Ghilardi N, Li J, de Sauvage FJ: IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms, Proc Natl Acad Sci USA 2003, 100:15047-15052
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 15047-15052
-
-
Lucas, S.1
Ghilardi, N.2
Li, J.3
de Sauvage, F.J.4
-
23
-
-
10744221849
-
WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production
-
Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, Takeda A, Zhang M, Hisaeda H, Mak TW, Yoshimura A, Yoshida H: WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 2003, 19:657-667
-
(2003)
Immunity
, vol.19
, pp. 657-667
-
-
Hamano, S.1
Himeno, K.2
Miyazaki, Y.3
Ishii, K.4
Yamanaka, A.5
Takeda, A.6
Zhang, M.7
Hisaeda, H.8
Mak, T.W.9
Yoshimura, A.10
Yoshida, H.11
-
24
-
-
0034687402
-
Development of Th1-type immune responses requires the type I cytokine receptor TCCR
-
Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A, Grewal IS, de Sauvage FJ: Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000, 407:916-920
-
(2000)
Nature
, vol.407
, pp. 916-920
-
-
Chen, Q.1
Ghilardi, N.2
Wang, H.3
Baker, T.4
Xie, M.H.5
Gurney, A.6
Grewal, I.S.7
de Sauvage, F.J.8
-
25
-
-
17944377950
-
WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection
-
Yoshida H, Hamano S, Senaldi G, Covey T, Faggioni R, Mu S, Xia M, Wakeham AC, Nishina H, Potter J, Saris CJ, Mak TW: WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001, 15:569-578
-
(2001)
Immunity
, vol.15
, pp. 569-578
-
-
Yoshida, H.1
Hamano, S.2
Senaldi, G.3
Covey, T.4
Faggioni, R.5
Mu, S.6
Xia, M.7
Wakeham, A.C.8
Nishina, H.9
Potter, J.10
Saris, C.J.11
Mak, T.W.12
-
26
-
-
0345570521
-
The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection
-
Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, Kastelein RA, Saris C, Hunter CA: The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003, 19:645-655
-
(2003)
Immunity
, vol.19
, pp. 645-655
-
-
Villarino, A.1
Hibbert, L.2
Lieberman, L.3
Wilson, E.4
Mak, T.5
Yoshida, H.6
Kastelein, R.A.7
Saris, C.8
Hunter, C.A.9
-
27
-
-
1842477302
-
Cutting edge: Early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection
-
Artis D, Johnson LM, Joyce K, Saris C, Villarino A, Hunter CA, Scott P: Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. J Immunol 2004, 172:4672-4675
-
(2004)
J Immunol
, vol.172
, pp. 4672-4675
-
-
Artis, D.1
Johnson, L.M.2
Joyce, K.3
Saris, C.4
Villarino, A.5
Hunter, C.A.6
Scott, P.7
-
28
-
-
14844355133
-
The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis
-
Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S: The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005, 174:3534-3544
-
(2005)
J Immunol
, vol.174
, pp. 3534-3544
-
-
Holscher, C.1
Holscher, A.2
Ruckerl, D.3
Yoshimoto, T.4
Yoshida, H.5
Mak, T.6
Saris, C.7
Ehlers, S.8
-
29
-
-
23444445743
-
Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice
-
Miyazaki Y, Inoue H, Matsumura M, Matsumoto K, Nakano T, Tsuda M, Hamano S, Yoshimura A, Yoshida H: Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol 2005, 175:2401-2407
-
(2005)
J Immunol
, vol.175
, pp. 2401-2407
-
-
Miyazaki, Y.1
Inoue, H.2
Matsumura, M.3
Matsumoto, K.4
Nakano, T.5
Tsuda, M.6
Hamano, S.7
Yoshimura, A.8
Yoshida, H.9
-
30
-
-
33747593830
-
-
Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, OShea JJ, Hennighausen L, Ernst M, Hunter CA: Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006, 7:937-945
-
Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, O"Shea JJ, Hennighausen L, Ernst M, Hunter CA: Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006, 7:937-945
-
-
-
-
31
-
-
33747588291
-
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
-
Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N: Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006, 7:929-936
-
(2006)
Nat Immunol
, vol.7
, pp. 929-936
-
-
Batten, M.1
Li, J.2
Yi, S.3
Kljavin, N.M.4
Danilenko, D.M.5
Lucas, S.6
Lee, J.7
de Sauvage, F.J.8
Ghilardi, N.9
-
32
-
-
35648988381
-
Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis
-
Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A: Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 2007, 179:3268-3275
-
(2007)
J Immunol
, vol.179
, pp. 3268-3275
-
-
Fitzgerald, D.C.1
Ciric, B.2
Touil, T.3
Harle, H.4
Grammatikopolou, J.5
Das Sarma, J.6
Gran, B.7
Zhang, G.X.8
Rostami, A.9
-
33
-
-
33646695436
-
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: Data from a randomized placebo-controlled trial
-
Meisner F, Walcher D, Gizard F, Kapfer X, Huber R, Noak A, Sunder-Plassmann L, Bach H, Haug C, Bachem M, Stojakovic T, Marz W, Hombach V, Koenig W, Staels B, Marx N: Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial. Arterioscler Thromb Vasc Biol 2006, 26:845-850
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 845-850
-
-
Meisner, F.1
Walcher, D.2
Gizard, F.3
Kapfer, X.4
Huber, R.5
Noak, A.6
Sunder-Plassmann, L.7
Bach, H.8
Haug, C.9
Bachem, M.10
Stojakovic, T.11
Marz, W.12
Hombach, V.13
Koenig, W.14
Staels, B.15
Marx, N.16
-
34
-
-
17344392308
-
A new mathematical model for relative quantification in real-time RT-PCR
-
Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45
-
(2001)
Nucleic Acids Res
, vol.29
-
-
Pfaffl, M.W.1
-
35
-
-
0037129827
-
-
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol 2002, 3: research 0034.1-0034.11
-
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol 2002, 3: research 0034.1-0034.11
-
-
-
-
36
-
-
8644227858
-
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression
-
Ushmorov A, Ritz O, Hummel M, Leithauser F, Moller P, Stein H, Wirth T: Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood 2004, 104:3326-3334
-
(2004)
Blood
, vol.104
, pp. 3326-3334
-
-
Ushmorov, A.1
Ritz, O.2
Hummel, M.3
Leithauser, F.4
Moller, P.5
Stein, H.6
Wirth, T.7
-
37
-
-
26444471700
-
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma
-
Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK: A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005, 437:759-763
-
(2005)
Nature
, vol.437
, pp. 759-763
-
-
Pascual, G.1
Fong, A.L.2
Ogawa, S.3
Gamliel, A.4
Li, A.C.5
Perissi, V.6
Rose, D.W.7
Willson, T.M.8
Rosenfeld, M.G.9
Glass, C.K.10
-
38
-
-
20044378485
-
EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation
-
Wirtz S, Becker C, Fantini MC, Nieuwenhuis EE, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, Neurath MF: EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J Immunol 2005, 174:2814-2824
-
(2005)
J Immunol
, vol.174
, pp. 2814-2824
-
-
Wirtz, S.1
Becker, C.2
Fantini, M.C.3
Nieuwenhuis, E.E.4
Tubbe, I.5
Galle, P.R.6
Schild, H.J.7
Birkenbach, M.8
Blumberg, R.S.9
Neurath, M.F.10
-
39
-
-
8344275053
-
Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice
-
Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S: Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004, 24:2137-2142
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 2137-2142
-
-
Branen, L.1
Hovgaard, L.2
Nitulescu, M.3
Bengtsson, E.4
Nilsson, J.5
Jovinge, S.6
-
40
-
-
0030974188
-
IFNgamma potentiates atherosclerosis in ApoE knock-out mice
-
Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C: IFNgamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997, 99:2752-2761
-
(1997)
J Clin Invest
, vol.99
, pp. 2752-2761
-
-
Gupta, S.1
Pablo, A.M.2
Jiang, X.3
Wang, N.4
Tall, A.R.5
Schindler, C.6
-
41
-
-
0021929537
-
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis
-
Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK: Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985, 76:125-131
-
(1985)
J Clin Invest
, vol.76
, pp. 125-131
-
-
Jonasson, L.1
Holm, J.2
Skalli, O.3
Gabbiani, G.4
Hansson, G.K.5
-
42
-
-
0024811224
-
Interferon gamma inhibits both proliferation and expression of differentiationspecific alpha-smooth muscle actin in arterial smooth muscle cells
-
Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G: Interferon gamma inhibits both proliferation and expression of differentiationspecific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med 1989, 170:1595-1608
-
(1989)
J Exp Med
, vol.170
, pp. 1595-1608
-
-
Hansson, G.K.1
Hellstrand, M.2
Rymo, L.3
Rubbia, L.4
Gabbiani, G.5
-
43
-
-
0033305213
-
Peroxisome proliferator-activated receptors: Nuclear control of metabolism
-
Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-688
-
(1999)
Endocr Rev
, vol.20
, pp. 649-688
-
-
Desvergne, B.1
Wahli, W.2
-
44
-
-
2442711384
-
Peroxisome proliferatoractivated receptors and atherogenesis: Regulators of gene expression in vascular cells
-
Marx N, Duez H, Fruchart JC, Staels B: Peroxisome proliferatoractivated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 2004, 94:1168-1178
-
(2004)
Circ Res
, vol.94
, pp. 1168-1178
-
-
Marx, N.1
Duez, H.2
Fruchart, J.C.3
Staels, B.4
-
45
-
-
33846468972
-
Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia
-
Xu J, Drew PD: Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia. J Immunol 2007, 178:1904-1913
-
(2007)
J Immunol
, vol.178
, pp. 1904-1913
-
-
Xu, J.1
Drew, P.D.2
-
46
-
-
0036779687
-
Emerging roles of PPARs in inflammation and immunity
-
Daynes RA, Jones DC: Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2002, 2:748-759
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 748-759
-
-
Daynes, R.A.1
Jones, D.C.2
-
47
-
-
33845970925
-
Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma
-
Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM, Rosenfeld MG, Glass CK: Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol Cell 2007, 25:57-70
-
(2007)
Mol Cell
, vol.25
, pp. 57-70
-
-
Ghisletti, S.1
Huang, W.2
Ogawa, S.3
Pascual, G.4
Lin, M.E.5
Willson, T.M.6
Rosenfeld, M.G.7
Glass, C.K.8
-
48
-
-
33846440515
-
Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways
-
Liu J, Guan X, Ma X: Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J Exp Med 2007, 204:141-152
-
(2007)
J Exp Med
, vol.204
, pp. 141-152
-
-
Liu, J.1
Guan, X.2
Ma, X.3
-
49
-
-
31544456342
-
Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation
-
Goriely S, Molle C, Nguyen M, Albarani V, Haddou NO, Lin R, De Wit D, Flamand V, Willems F, Goldman M: Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 2006, 107:1078-1084
-
(2006)
Blood
, vol.107
, pp. 1078-1084
-
-
Goriely, S.1
Molle, C.2
Nguyen, M.3
Albarani, V.4
Haddou, N.O.5
Lin, R.6
De Wit, D.7
Flamand, V.8
Willems, F.9
Goldman, M.10
-
50
-
-
11244336489
-
Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein
-
Liu J, Guan X, Tamura T, Ozato K, Ma X: Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem 2004, 279:55609-55617
-
(2004)
J Biol Chem
, vol.279
, pp. 55609-55617
-
-
Liu, J.1
Guan, X.2
Tamura, T.3
Ozato, K.4
Ma, X.5
-
51
-
-
0028987382
-
LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha
-
Herrero JA, Mathew P, Paya CV: LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha. J Virol 1995, 69:2168-2174
-
(1995)
J Virol
, vol.69
, pp. 2168-2174
-
-
Herrero, J.A.1
Mathew, P.2
Paya, C.V.3
-
52
-
-
0031573597
-
EBV induces the production and release of IL-8 and macrophage inflammatory protein-1 alpha in human neutrophils
-
McColl SR, Roberge CJ, Larochelle B, Gosselin J: EBV induces the production and release of IL-8 and macrophage inflammatory protein-1 alpha in human neutrophils. J Immunol 1997, 159:6164-6168
-
(1997)
J Immunol
, vol.159
, pp. 6164-6168
-
-
McColl, S.R.1
Roberge, C.J.2
Larochelle, B.3
Gosselin, J.4
-
53
-
-
30044451752
-
Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: Implications for plaque inflammation
-
de Boer OJ, Teeling P, Idu MM, Becker AE, van der Wal AC: Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: implications for plaque inflammation. Atherosclerosis 2006, 184:322-329
-
(2006)
Atherosclerosis
, vol.184
, pp. 322-329
-
-
de Boer, O.J.1
Teeling, P.2
Idu, M.M.3
Becker, A.E.4
van der Wal, A.C.5
|